Cargando…

Pharmacological treatment in patients with aortic dissection

OBJECTIVES: To describe medical management in aortic dissection (AD) and to analyse the possible associations between antihypertensive, antithrombotic, anticoagulant and statin agents, respectively, and long-term survival. METHODS: From Swedish medical registers, all patients diagnosed with AD in 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Smedberg, Christian, Hultgren, Rebecka, Leander, Karin, Steuer, Johnny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677041/
https://www.ncbi.nlm.nih.gov/pubmed/36396295
http://dx.doi.org/10.1136/openhrt-2022-002082
_version_ 1784833724632793088
author Smedberg, Christian
Hultgren, Rebecka
Leander, Karin
Steuer, Johnny
author_facet Smedberg, Christian
Hultgren, Rebecka
Leander, Karin
Steuer, Johnny
author_sort Smedberg, Christian
collection PubMed
description OBJECTIVES: To describe medical management in aortic dissection (AD) and to analyse the possible associations between antihypertensive, antithrombotic, anticoagulant and statin agents, respectively, and long-term survival. METHODS: From Swedish medical registers, all patients diagnosed with AD in 2006–2015 were identified. Filled prescriptions prior to admission and within 1 year from discharge in patients discharged and alive at 30 days were registered. Associations between pharmacological treatment and long-term survival were analysed using Cox proportional hazards models. RESULTS: Of 3951 patients hospitalised with acute AD, 3046 (77%) were discharged and alive at 30 days. In hospitalised patients, mean age was 66 years (SD 13), and 36% (n=1098) were women. Within 1 year from discharge, 96% (n=2939) had at least one antihypertensive drug. Beta blocker was the most commonly used drug type (90%, n=2741). Statin treatment (47%, n=1418) was associated with higher long-term survival; HR 0.74 (95% CI 0.63 to 0.87, p<0.001). The positive association between statins and long-term survival remained, in subgroup analysis, in medically managed patients (HR 0.72 (95% CI 0.60 to 0.86, p<0.001)), but not in patients undergoing surgical repair (HR 0.82 (95% CI 0.58 to 1.14, p=0.230)). Beta blockers were associated with favourable long-term survival in surgically managed patients (HR 0.58 (95% CI 0.35 to 0.97, p=0.038)) but not in medically managed patients (HR 0.93 (95% CI 0.72 to 1.12, p=0.057)). Neither antiplatelet therapy nor anticoagulants were associated with long-term survival. CONCLUSIONS: Statin treatment was associated with favourable long-term outcome in medically managed AD patients, whereas treatment with beta blocker was associated with higher survival only in surgically managed AD patients. Statin use as well as optimal antihypertensive therapy in the chronic stage of the disease need to be further analysed, preferably in randomised controlled trials.
format Online
Article
Text
id pubmed-9677041
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-96770412022-11-22 Pharmacological treatment in patients with aortic dissection Smedberg, Christian Hultgren, Rebecka Leander, Karin Steuer, Johnny Open Heart Aortic and Vascular Disease OBJECTIVES: To describe medical management in aortic dissection (AD) and to analyse the possible associations between antihypertensive, antithrombotic, anticoagulant and statin agents, respectively, and long-term survival. METHODS: From Swedish medical registers, all patients diagnosed with AD in 2006–2015 were identified. Filled prescriptions prior to admission and within 1 year from discharge in patients discharged and alive at 30 days were registered. Associations between pharmacological treatment and long-term survival were analysed using Cox proportional hazards models. RESULTS: Of 3951 patients hospitalised with acute AD, 3046 (77%) were discharged and alive at 30 days. In hospitalised patients, mean age was 66 years (SD 13), and 36% (n=1098) were women. Within 1 year from discharge, 96% (n=2939) had at least one antihypertensive drug. Beta blocker was the most commonly used drug type (90%, n=2741). Statin treatment (47%, n=1418) was associated with higher long-term survival; HR 0.74 (95% CI 0.63 to 0.87, p<0.001). The positive association between statins and long-term survival remained, in subgroup analysis, in medically managed patients (HR 0.72 (95% CI 0.60 to 0.86, p<0.001)), but not in patients undergoing surgical repair (HR 0.82 (95% CI 0.58 to 1.14, p=0.230)). Beta blockers were associated with favourable long-term survival in surgically managed patients (HR 0.58 (95% CI 0.35 to 0.97, p=0.038)) but not in medically managed patients (HR 0.93 (95% CI 0.72 to 1.12, p=0.057)). Neither antiplatelet therapy nor anticoagulants were associated with long-term survival. CONCLUSIONS: Statin treatment was associated with favourable long-term outcome in medically managed AD patients, whereas treatment with beta blocker was associated with higher survival only in surgically managed AD patients. Statin use as well as optimal antihypertensive therapy in the chronic stage of the disease need to be further analysed, preferably in randomised controlled trials. BMJ Publishing Group 2022-11-17 /pmc/articles/PMC9677041/ /pubmed/36396295 http://dx.doi.org/10.1136/openhrt-2022-002082 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Aortic and Vascular Disease
Smedberg, Christian
Hultgren, Rebecka
Leander, Karin
Steuer, Johnny
Pharmacological treatment in patients with aortic dissection
title Pharmacological treatment in patients with aortic dissection
title_full Pharmacological treatment in patients with aortic dissection
title_fullStr Pharmacological treatment in patients with aortic dissection
title_full_unstemmed Pharmacological treatment in patients with aortic dissection
title_short Pharmacological treatment in patients with aortic dissection
title_sort pharmacological treatment in patients with aortic dissection
topic Aortic and Vascular Disease
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9677041/
https://www.ncbi.nlm.nih.gov/pubmed/36396295
http://dx.doi.org/10.1136/openhrt-2022-002082
work_keys_str_mv AT smedbergchristian pharmacologicaltreatmentinpatientswithaorticdissection
AT hultgrenrebecka pharmacologicaltreatmentinpatientswithaorticdissection
AT leanderkarin pharmacologicaltreatmentinpatientswithaorticdissection
AT steuerjohnny pharmacologicaltreatmentinpatientswithaorticdissection